0001832415-23-000003.txt : 20230421 0001832415-23-000003.hdr.sgml : 20230421 20230421160134 ACCESSION NUMBER: 0001832415-23-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230421 DATE AS OF CHANGE: 20230421 EFFECTIVENESS DATE: 20230421 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Better Therapeutics, Inc. CENTRAL INDEX KEY: 0001832415 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-479714 FILM NUMBER: 23836267 BUSINESS ADDRESS: STREET 1: 548 MARKET ST. #49404 CITY: SAN FRANCISCO STATE: CA ZIP: 94101 BUSINESS PHONE: 415-887-2311 MAIL ADDRESS: STREET 1: 548 MARKET ST. #49404 CITY: SAN FRANCISCO STATE: CA ZIP: 94101 FORMER COMPANY: FORMER CONFORMED NAME: Mountain Crest Acquisition Corp II DATE OF NAME CHANGE: 20201116 D 1 primary_doc.xml X0708 D LIVE 0001832415 Better Therapeutics, Inc. 548 MARKET ST. #49404 SAN FRANCISCO CA CALIFORNIA 94104 (415) 887-2311 DELAWARE Mountain Crest Acquisition Corp II Corporation true 2020 Frank Karbe 548 Market St. #49404 San Francisco CA CALIFORNIA 94104 Executive Officer Director David Perry 548 Market St. #49404 San Francisco CA CALIFORNIA 94104 Executive Officer Director Mark Berman 548 Market St. #49404 San Francisco CA CALIFORNIA 94104 Executive Officer Kristin Wynholds 548 Market St. #49404 San Francisco CA CALIFORNIA 94104 Executive Officer Mark Heinen 548 Market St. #49404 San Francisco CA CALIFORNIA 94104 Executive Officer Richard Carmona c/o Better Therapeutics, Inc. 548 Market St. #49404 San Francisco CA CALIFORNIA 94104 Director Andrew Armanino c/o Better Therapeutics, Inc. 548 Market St. #49404 San Francisco CA CALIFORNIA 94104 Director Risa Lavizzo-Mourey c/o Better Therapeutics, Inc. 548 Market St. #49404 San Francisco CA CALIFORNIA 94104 Director Geoffrey Parker c/o Better Therapeutics, Inc. 548 Market St. #49404 San Francisco CA CALIFORNIA 94104 Director Elder Granger c/o Better Therapeutics, Inc. 548 Market St. #49404 San Francisco CA CALIFORNIA 94104 Director Biotechnology Decline to Disclose 06b false 2023-04-06 false true false 0 Chardan Capital Markets LLC 120128 None None 17 State Street, Suite 2130 New York NY NEW YORK 10004 AR ARKANSAS CA CALIFORNIA FL FLORIDA NY NEW YORK true Brookline Capital Markets, a division of Arcadia Securities, LLC 44656 None None 1370 Avenue of the Americas, 29th Floor New York NY NEW YORK 10019 CA CALIFORNIA FL FLORIDA NY NEW YORK true 6500001 6500001 0 Private placement of shares of common stock at a price of $0.825 per share. false 9 325000 0 0 false Better Therapeutics, Inc. /s/ Frank Karbe Frank Karbe Chief Executive Officer 2023-04-21